Piramal Pharma to Invest USD 90 Million in Expanding US Facilities

Piramal Pharma to Invest USD 90 Million in Expanding US FacilitiesMumbai-based Piramal Pharma Limited has made a USD 90 million investment to build out two of its facilities in the US. The announcement comes on the backdrop of the 2025 Select USA...

Emcutix in Collaboration with Canada-based Mantra Pharma Launch UREADERM

Emcutix Biopharmaceuticals Ltd., in collaboration with Canada-based Mantra Pharma Inc. – both subsidiaries of Emcure Pharmaceuticals Ltd. – has announced the pan-India launch of Ureaderm 10 percent & 20 percent, a urea-based moisturizer in cream

India Eyes Kuwait Pharma Market Amid Growing Import Demand

India Eyes Kuwait Pharma Market Amid Growing Import DemandIn a bid to tap into increasing pharmaceutical demand in Kuwait, the Indian Pharmaceuticals Export Promotion Council of India (Pharmexcil) is seeking comments from Indian pharma...

Solara Active Pharma's Ambernath Plant Clears USFDA Check

Solara Active Pharma Sciences reported that its Ambernath facility in Maharashtra, having multiple products manufacturing, passed inspection by the United States Food and Drug Administration (USFDA)...

Export Ban to Pakistan Won't Impact Himachal's Pharma Sector

The Centre's latest move to impose a ban on the export of pharmaceuticals to Pakistan, after the April 22 terror attack in Pahalgam, which killed 26 people, will have negligible or no effect on Himachal Pradesh's pharmaceutical industry...

Senores Pharmaceuticals Acquires USFDA-Approved ANDA for Tramadol Tablets

Senores Pharmaceuticals Limited, a world class research based pharmaceutical firm has made a disclosure that its 100% owned subsidiary...

FDC Ltd Recalls Over 60,000 Bottles of Ophthalmic Solution in US

FDC Ltd, a drug company from Mumbai, has had to recall more than 60,000 bottles of Timolol Maleate Ophthalmic Solution USP across the US. The trouble started when they found out the bottles were faulty the cap’s spike was getting jammed in the noz...

New Schedule M Requirements Pose Challenge for Drug Manufacturers

According to Health Ministry officials, there are about 10,000 medium and small manufacturing businesses and only 100 of them submitted applications.

ProBioGen & Polpharma Biologics team up for biosimilar cell lines

Cell line development expert ProBioGen has declared the partnership with biotech firm Polpharma Biologics to deliver cell line for one of the biosimilar molecules being developed by Polpharma...

Indian Pharma Faces US Setback Amid Push for Domestic Drug Manufacturing

Indian pharmaceutical companies may encounter significant hurdles in the US following President Donald Trump’s new executive orders aimed at promoting domestic drug production...

© 2025 India Pharma Outlook. All Rights Reserved.

Safety Monitoring